Analysing the mutational status of PIK3CA in circulating tumor cells from metastatic breast cancer patients
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Analysing the mutational status of PIK3CA
in circulating tumor cells from metastatic breast cancer patients
Authors
Keywords
-
Journal
Molecular Oncology
Volume 7, Issue 5, Pages 976-986
Publisher
Wiley
Online
2013-07-14
DOI
10.1016/j.molonc.2013.07.007
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Detection of Tumor PIK3CA Status in Metastatic Breast Cancer Using Peripheral Blood
- (2012) M. J. Higgins et al. CLINICAL CANCER RESEARCH
- Single Cell Profiling of Circulating Tumor Cells: Transcriptional Heterogeneity and Diversity from Breast Cancer Cell Lines
- (2012) Ashley A. Powell et al. PLoS One
- Gene expression profile of circulating tumor cells in breast cancer by RT-qPCR
- (2011) Areti Strati et al. BMC CANCER
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- PIK3CA mutation, but not PTEN loss of function, determines the sensitivity of breast cancer cells to mTOR inhibitory drugs
- (2011) B Weigelt et al. ONCOGENE
- HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial
- (2010) Tanja Fehm et al. BREAST CANCER RESEARCH AND TREATMENT
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Detection and HER2 Expression of Circulating Tumor Cells: Prospective Monitoring in Breast Cancer Patients Treated in the Neoadjuvant GeparQuattro Trial
- (2010) S. Riethdorf et al. CLINICAL CANCER RESEARCH
- PIK3CA Mutations May Be Discordant between Primary and Corresponding Metastatic Disease in Breast Cancer
- (2010) J. Dupont Jensen et al. CLINICAL CANCER RESEARCH
- PI3K/Akt and GSK-3β prevents in a differential fashion the malignant phenotype of colorectal cancer cells
- (2010) Wallace Martins de Araújo et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Molecular Biomarker Analyses Using Circulating Tumor Cells
- (2010) Elizabeth A. Punnoose et al. PLoS One
- Association between gain-of-function mutations in PIK3CA and resistance to HER2-targeted agents in HER2-amplified breast cancer cell lines
- (2009) Y. Kataoka et al. ANNALS OF ONCOLOGY
- HER2 as marker for the detection of circulating tumor cells
- (2009) Volkmar Müller et al. BREAST CANCER RESEARCH AND TREATMENT
- Molecular characterization of circulating tumor cells in large quantities of contaminating leukocytes by a multiplex real-time PCR
- (2009) Anieta M. Sieuwerts et al. BREAST CANCER RESEARCH AND TREATMENT
- Phosphatidylinositol-3-kinase and AKT1 mutations occur early in breast carcinoma
- (2009) Jennifer Dunlap et al. BREAST CANCER RESEARCH AND TREATMENT
- HER-2, Notch, and Breast Cancer Stem Cells: Targeting an Axis of Evil
- (2009) H. Korkaya et al. CLINICAL CANCER RESEARCH
- Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data
- (2009) Howard I Scher et al. LANCET ONCOLOGY
- Cancer micrometastases
- (2009) Klaus Pantel et al. Nature Reviews Clinical Oncology
- High-Resolution Melting Analysis for Rapid Detection ofKRAS, BRAF,andPIK3CAGene Mutations in Colorectal Cancer
- (2008) Lisa Simi et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- PIK3CA Exon 20 Mutation is Independently Associated with a Poor Prognosis in Breast Cancer Patients
- (2008) Yuen-Liang Lai et al. ANNALS OF SURGICAL ONCOLOGY
- NVP-BEZ235, a Dual PI3K/mTOR Inhibitor, Prevents PI3K Signaling and Inhibits the Growth of Cancer Cells with Activating PI3K Mutations
- (2008) V. Serra et al. CANCER RESEARCH
- An Integrative Genomic and Proteomic Analysis of PIK3CA, PTEN, and AKT Mutations in Breast Cancer
- (2008) K. Stemke-Hale et al. CANCER RESEARCH
- Phosphatidylinositol 3-Kinase Hyperactivation Results in Lapatinib Resistance that Is Reversed by the mTOR/Phosphatidylinositol 3-Kinase Inhibitor NVP-BEZ235
- (2008) P. J.A. Eichhorn et al. CANCER RESEARCH
- Prognostic Value of the Molecular Detection of Circulating Tumor Cells Using a Multimarker Reverse Transcription-PCR Assay for Cytokeratin 19, Mammaglobin A, and HER2 in Early Breast Cancer
- (2008) M. Ignatiadis et al. CLINICAL CANCER RESEARCH
- Multiplexed Assays for Detection of Mutations in PIK3CA
- (2008) R. E. Board et al. CLINICAL CHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started